A bill to amend the Federal Food, Drug, and Cosmetic Act in order to impose certain restrictions on oral representations made to physicians and pharmacists regarding drugs, and to impose certain restrictions on the written advertising of drugs.

1/1
Status In Committee
Sponsor Gaylord Nelson
Citation 94-S-1314
Actions 2
Introduced Mar 24th, 1975
Cosponsors
Last Action Mar 24th, 1975
Policy Area
Introduced Senate Mar 24
Senate
House
President
Enacted

Summary

AI Guide

What this bill does

Loading AI analysis…

Provides that no information with respect to any drug shall be given orally to any licensed practitioner or pharmacist by any employee or person representing a drug firm unless immediately prior to the time of such oral information, a copy is given of a document approved by the Secretary of Health, Education, and Welfare relating to such drug and containing such information about such drug as the Secretary may by regulation require. Provides that all drug advertisements must be approved by the Secretary under specified guidelines. Provides that all published articles intended for health professionals dealing with drugs shall, under specified regulations, identify the person or persons who provided financial support to the author for his writing or research.

Actions

2
Senate
INTRODUCED
INTRODUCED
Mar 24, 1975
ON FLOOR
REFERRED TO COMMITTEE
Font size

No Bill Text yet Available

Text for this piece of legislation has not yet been uploaded — check back in a few days.